Hyman Muss
Director, Geriatric Oncology · University of North Carolina Hospitals
Credentials: · · ·
History
- 1971–1974
Hematology and Medical Oncology
- 1968–1971
Internal Medicine
Research
New England Journal of Medicine · 2003 · 1,382 citations
Journal of Clinical Oncology · 2003 · 1,171 citations
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Cancer Discovery · 2017 · 1,094 citations
64 papers · 6 as a fellow
- CS
60 papers · 34 as a resident
54 papers
- DW
52 papers
- GW
48 papers · 26 as a fellow
40 papers
- CH
35 papers
- DJ
35 papers · 2 as a fellow
Grants
- 2019–2024
UNC Geriatric Oncology Training Grant (UNC-GO)
National Cancer Institute · T32
Contact PI · $729.4K · Univ of North Carolina Chapel Hill
- 2016–2021
Biomarkers of Molecular Age to Predict the Toxicity of Cancer Chemotherapy
National Cancer Institute · R01
Contact PI · $2.5M · Univ of North Carolina Chapel Hill
- 1978–2005
Cancer Center Support Grant (Ccsg)
National Cancer Institute · P30
Project lead · $715.5K · University of Vermont & St Agric College
- 1998–2003
Cancer Center Calgb Participation
National Cancer Institute · U10
Contact PI · $527K · University of Vermont & St Agric College
Clinical trials
- 2024–2027
A Novel Approach Utilizing Organ Specific Age Proteomics
Principal investigator · Recruiting
UNC Lineberger Comprehensive Cancer Center
- 2023–2028
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
Principal investigator · Active not recruiting
UNC Lineberger Comprehensive Cancer Center
- 2022
Patterns of Natural Aging and the Role of Senescence Registry
Principal investigator · Completed
University of North Carolina, Chapel Hill
- 2020–2024
LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+)
Principal investigator · Completed
UNC Lineberger Comprehensive Cancer Center